Abstract
Spironolactone is a synthetic aldosterone receptor antagonist, with a role off-label in various dermatological conditions. Its antiandrogenic properties make it suitable for diseases in which excess androgen production results in unwanted and psychologically distressing manifestations in susceptible females. Treatment with spironolactone aims to attenuate androgen-mediated conditions including acne, hidradenitis suppurativa, female pattern hair loss and hirsutism. We discuss the emerging utility of spironolactone in dermatology, its potential adverse effects and considerations for monitoring.
© 2020 British Association of Dermatologists.
MeSH terms
-
Acne Vulgaris / drug therapy*
-
Acne Vulgaris / pathology
-
Adult
-
Alopecia / drug therapy
-
Alopecia / pathology
-
Dermatology / standards*
-
Dermatology / statistics & numerical data
-
Drug Monitoring / methods
-
Female
-
Hidradenitis Suppurativa / drug therapy
-
Hirsutism / drug therapy
-
Hirsutism / pathology
-
Humans
-
Hyperkalemia / chemically induced
-
Hypotension / chemically induced
-
Middle Aged
-
Mineralocorticoid Receptor Antagonists / adverse effects
-
Mineralocorticoid Receptor Antagonists / pharmacology
-
Mineralocorticoid Receptor Antagonists / therapeutic use*
-
Retrospective Studies
-
Spironolactone / adverse effects
-
Spironolactone / pharmacology
-
Spironolactone / therapeutic use*
-
Treatment Outcome
Substances
-
Mineralocorticoid Receptor Antagonists
-
Spironolactone